$68.05 0.00 (%) Mylan N.V. - NASDAQ

Apr. 20, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 19, 2015 | 19:10PM EST
  2. Mylan

    IBD | Apr. 17, 2015 | 18:51PM EST
  3. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 16:37PM EST
  4. Teva Getting Serious About Mylan Bid, Says Report

    IBD | Apr. 17, 2015 | 15:54PM EST
  5. 8 IBD 50 Stocks Bucking The Market Sell-Off

    IBD | Apr. 17, 2015 | 15:36PM EST
  6. Mylan: There's No Logic In The Teva Merger Rumor

    Benzinga | Apr. 17, 2015 | 15:17PM EST
  7. Stocks Bleed Some More; Nasdaq Breaches Support Level

    IBD | Apr. 17, 2015 | 14:57PM EST
  8. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  9. Momenta, Novartis Win FDA Nod For Generic Copaxone

    IBD | Apr. 16, 2015 | 14:39PM EST
  10. Stocks In Red Ahead Of Close; Alibaba At Post-IPO Low

    IBD | Mar. 3, 2015 | 15:14PM EST
  11. Stocks Off Lows In Afternoon; Akorn Dives 10%

    IBD | Mar. 3, 2015 | 13:23PM EST
  12. Mylan Revenue Tops In Q4

    IBD | Mar. 2, 2015 | 18:45PM EST
  13. Big Cap 20 Reflecting Market Leadership

    IBD | Mar. 2, 2015 | 18:44PM EST
  14. Mylan Q4 Earnings, Guidance In Line As Growth Ramps

    IBD | Mar. 2, 2015 | 17:14PM EST
  15. Earnings Scheduled For March 2, 2015

    Benzinga | Mar. 2, 2015 | 04:44AM EST
  16. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  17. Five Top-Rated Medical Stocks To Keep Monitoring

    IBD | Feb. 23, 2015 | 18:22PM EST
  18. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  19. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  20. John Paulson's Top Buys

    GuruFocus | Feb. 21, 2015 | 22:52PM EST
  21. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga | Feb. 18, 2015 | 16:12PM EST
  22. Stocks Turn Positive; Apple Marks New High

    IBD | Feb. 17, 2015 | 13:34PM EST
  23. Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR

    Benzinga | Feb. 9, 2015 | 11:01AM EST
  24. Weekly CFO Sells Highlight: Sherwin-Williams Co, Facebook Inc, Mylan Inc.

    GuruFocus | Feb. 8, 2015 | 21:00PM EST
  25. Weekly CEO Sells Highlight: Family Dollar Stores Inc, Texas Instruments Inc, Mylan Inc, and ...

    GuruFocus | Feb. 8, 2015 | 20:58PM EST
  26. Weekly Insider Sells Highlight: MYL, QRVO, HON, JBHT

    GuruFocus | Feb. 8, 2015 | 20:57PM EST
  27. Three Reasons To Let Akorn Fall Into Your Portfolio

    IBD | Feb. 6, 2015 | 11:11AM EST
  28. Benzinga's M&A Chatter for Monday February 2, 2015

    Benzinga | Feb. 2, 2015 | 19:07PM EST
  29. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  30. Benzinga's Volume Movers

    Benzinga | Feb. 2, 2015 | 10:29AM EST
  31. Stock Futures Trim Early Gains; Exxon Mobil Up After Earnings

    IBD | Feb. 2, 2015 | 09:10AM EST
  32. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | Feb. 2, 2015 | 07:01AM EST
  33. Big Cap Stocks Mylan, American Tower Near Buy Points

    IBD | Jan. 26, 2015 | 18:42PM EST
  34. Mylan Labs expanded

    IBD | Jan. 26, 2015 | 18:40PM EST
  35. Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent

    Benzinga | Jan. 26, 2015 | 10:59AM EST
  36. Cramer Weighs In On Transocean LTD, Mylan Inc And Honda Motor Co Ltd

    Benzinga | Jan. 25, 2015 | 14:42PM EST
  37. Teva Pharmaceutical

    IBD | Jan. 20, 2015 | 18:45PM EST
  38. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  39. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  40. Mylan Launches Generic Diovan® Tablets

    Benzinga | Jan. 5, 2015 | 13:01PM EST
  41. Will 2015 Be Different For Big Cap Stocks?

    IBD | Dec. 29, 2014 | 17:27PM EST
  42. Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Dec. 18, 2014 | 04:31AM EST
  43. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  44. Mylan Launches First Generic Version Of Orapred ODT

    Benzinga | Dec. 11, 2014 | 07:04AM EST
  45. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  46. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  47. Great Stocks In 2014: Airline, Video Game, Drugs Lead

    IBD | Dec. 4, 2014 | 18:53PM EST
  48. Medical Issues Keep Climbing Into Sell Zone

    IBD | Dec. 4, 2014 | 18:20PM EST
  49. Mylan Receives Tentative FDA Approval For Pediatric Formulations Of Abacavir/Lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative

    Benzinga | Dec. 4, 2014 | 10:01AM EST
  50. Weekly CFO Sells Highlight: Hospira Inc, Rockwood Holdings Inc, Mylan Inc.

    GuruFocus | Nov. 30, 2014 | 13:58PM EST
Trading Center